Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03425942
Other study ID # LIU-002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 9, 2018
Est. completion date May 14, 2019

Study information

Verified date January 2021
Source Linkoeping University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cognitive behavioural therapy (CBT), that is designed to be short, concise and user friendly is compared to applied relaxation techniques as treatment for insomnia comorbid with chronic pain. Both treatments are administered via internet and participants are randomized to ether treatment arm.


Description:

Internet treatment with therapist support means that measurements are collected through the Internet. Participants are recruited from a specialized pain clinic for chronic pain. All patients with sleep complaints (Insomnia Severity Index > 14) at their first visit through 2016-01-01 to 2017-07-31 are asked for participation via mail. Volunteers sign informed consent and undergo a online screening. If matching the inclusion criteria, they are contacted for a telephone interview. Subjects are assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criterion for insomnia disorder, M.I.N.I. (screening for psychiatric comorbidity) and the other inclusion/exclusion criteria. The treatment, that is designed to be short, concise and user friendly as it is meant to be usable as an adjunct treatment to other main interventions for chronic pain. The treatment lasts for five weeks and focuses on the most potent CBT technics for insomnia; sleep restriction and stimulus control. Randomization is conducted by university staff not otherwise involved in this study. Participants have equal chance to be allocated to ether CBT or applied relaxation techniques (active controls). The relaxation treatment lasts for the same amount of time (five weeks) and is designed to require similar weekly effort. Both groups fill in sleep diaries every week and weekly feedback is provided by master students supervised by clinical psychologists. The overall hypothesis is that CBT leads to greater symptom reduction (according to the Insomnia Severity Index) compared to applied relaxation techniques.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date May 14, 2019
Est. primary completion date May 7, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Insomnia severity index (ISI) score > 14 - Chronic pain Exclusion Criteria: - Shift worker or employed as a driver, operator of dangerous equipment and such - Sleep apnea, restless legs syndrome, narcolepsy, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Bipolar disorder, psychotic disorders, ongoing substance abuse - Having received CBT for insomnia during the latest year - Pregnancy - Severe somatic disorder (such as ongoing cancer, severe neurological condition, insufficiently treated cardiac condition) - Impaired movement to such a degree that going to bed or getting out of bed requires assistance - Not being able read or wright in Swedish - Not having an internet-connected computer, cellular phone or tablet

Study Design


Related Conditions & MeSH terms

  • Chronic Pain
  • Insomnia Due to Medical Condition
  • Sleep Initiation and Maintenance Disorders

Intervention

Behavioral:
Internet Cognitive Behavioral Therapy for insomnia (ICBT-i)
This intervention lasts for five weeks. The intervention is internet-based and mainly consists of the most potent CBT technics i.e. sleep restriction and stimulus control. Weekly feedback is provided by master students supervised by clinical psychologists.
Internet Applied Relaxation Techniques (IART-i)
This intervention lasts for five weeks. The intervention is internet-based and consists of different common applied relaxation exercises and treatments. Weekly feedback is provided by master students supervised by clinical psychologists.

Locations

Country Name City State
Sweden Rehabilitation medicine, IMH, Linköping University Linköping Östergötland

Sponsors (1)

Lead Sponsor Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Pain spreading (PS) Number of anatomical regions with pain out of 36 anatomical areas. Change from baseline pain spreading (PS) at 6 months
Other Negative Effects Questionnaire (NEQ) Monitoring and Reporting Adverse and Unwanted Events (32 items). Range 0-128 where a higher value indicates more adverse events. at 5 weeks and at 6 months
Other Patient Health Questionnaire (PHQ-4) Measures depressive symptoms and anxiety. Range 0-12 where a higher value indicates more depressive or anxiety symptoms. Change from baseline health (PHQ-4) at 5 weeks
Primary Insomnia Severity Index (ISI) Measures degree of insomnia. Range 0-28 where a higher value indicates worse sleep. Change from baseline insomnia severity (ISI) at 6 months
Secondary Sleep diary Basis for sleep latency, total sleep time, wake time after sleep onset and sleep efficiency. Daily during treatment (five weeks).
Secondary The Karolinska Sleepiness Scale (KSS) Measures sleepiness on a single item numeric rating scale. Range 1-9, where a higher value indicates more sleepiness. Change from baseline sleepiness (KSS) at 5 weeks
Secondary Patient Health Questionnaire (PHQ-9) Measures depressive symptoms. Range 0-27, where a higher value indicates more depressive symptoms. Change from baseline health (PHQ-9) at 6 months
Secondary Generalised Anxiety Disorder 7-item scale (GAD-7) Measures anxiety symptoms. Range 0-21 where a higher value indicates more anxiety. Change from baseline anxiety (GAD-7) at 6 months
Secondary Pain intensity (NRS) Eleven stepped numeric rating scale (NRS) for average pain last seven days. Higher values indicate higher pain intensity. Change from baseline pain intensity (NRS) at 6 months
Secondary Pain Disability Index (PDI) Quantifying pain related disability. Range 0-70 where a higher value indicates more disability. Change from baseline disability (PDI) at 6 months
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain